Effects of ezetimibe on visceral fat in patients with metabolic syndrome: a randomized controlled study

Trial Profile

Effects of ezetimibe on visceral fat in patients with metabolic syndrome: a randomized controlled study

Completed
Phase of Trial: Phase II

Latest Information Update: 17 May 2016

At a glance

  • Drugs Ezetimibe (Primary)
  • Indications Hypercholesterolaemia; Insulin resistance; Metabolic syndrome; Obesity
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Dec 2012 Results published in the European Journal of Clinical Investigation.
    • 04 Oct 2012 Results presented at the 24th Scientific Meeting of the International Society of Hypertension.
    • 03 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top